The Next Health thematic track is designed to take a closer look at the main areas of healthcare R&D as well as investment. We will be talking biomedical research, neuroscience and neurotech. We will also examine the impact of machine learning and artificial intelligence on healthcare industry.

• The holistic approach to treating patients
• Managing cancer as a chronic illness
• Effectiveness of pharmacology vs technology in treatment of mental disorders
• Biotech investments: research directions and trends
• Transformation of the healthcare industry by retail and tech giants
• Lessons for healthcare from the banking industry
• Turning data into knowledge

• Healthcare policymakers
• CEOs of pharmaceutical companies
• Healthcare disruptors
• R&D experts
• Medical doctors
• Healthcare researchers
• Health IT professionals

Łukasz Szumowski, Ministry of Health
Wiktor Janicki, Roche
Jarosław Oleszczuk, AstraZeneca
Paweł Surówka, PZU
Krystian Jażdżewski, Warsaw Genomics
Janis Naeve, Amgen Ventures
Katarzyna Kacperska, Novo Nordisk
Patrick Dey, Amgen
Baptiste Billoir, AgenT
Miklós Szócska, EIT Health
Balázs Fürjes, EIT Health InnoStars
Erik Lommerde, Novo Nordisk
Anu Jalanko, FinnGen
Philip Tagari, Amgen
Gladys Nunez, Amgen Ventures
Magdalena Marciniak, Selvita
Janusz Cieszyński, Ministry of Health
Maciej Drozdz, Johnson & Johnson Innovation
John Bason, PFR Life Science
Tomasz Perkowski, Foundation for Polish Science
Gábor Sztaniszláv, Amgen
Paul van Arkel, Novartis
Andrzej Rys, Innovative Medicines Initiative / EU Commission
Radosław Śierpiński, Medical Research Agency
Roland Kozłowski, Life Science Innovations
Dominika Kwaśnicka, SWPS University Wroclaw
Radosław Sierpiński, Medical Research Agency
Mishal Patel, AstraZeneca
Jack Kreindler, Centre for Health and Human Performance,
Aleksandra Krygiel-Nael, Janssen
Michał Wszoła, Foundation of Research and Science Development
Klaudia Szklarczyk-Smolana, Intelliseq
Paweł Biernat, Biotts
Marcin Kruk, Pfizer
Artur Nowak, Evidence Prime
Paweł Kunstman, Evidence Prime
Mateusz Sagan, SDS Optic